0
Sol-Gel Technologies Ltd. Banner Image

Sol-Gel Technologies Ltd. has reached its limit for free report views

Work for Sol-Gel Technologies Ltd.? Upgrade Your Profile and unlock all your annual reports.

Sol-Gel Technologies Ltd.

  • Ticker SLGL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Sol-Gel Technologies Ltd. Logo Image
  • 11-50 Employees
  • Based in Ness Ziona, Israel
Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. Their lead product candidates, VERED for the treatment of papulopustular rosacea and TWIN and SIRS-T for the treatment of acne vulgaris (“acne”) are based upon their proprietary microencapsulation delivery system. This technology consists of microcapsulesMore made of silica. Based on their pre-clinical and clinical data, this delivery system should enable them to develop and commercialize dermatological drug products that are more effective and/or have fewer side effects than currently marketed drugs.
Sol-Gel Technologies Ltd.

Most Recent Annual Report

Sol-Gel Technologies Ltd. MOST RECENT 2020 Annual Report

Report Locked. Sol-Gel Technologies Ltd. has reached its limit for free report views.

Older/Archived Annual Reports